These findings indicate that PCT is a more reliable biomarker than CRP for early detection of bloodstream infections in febrile neutropenic pediatric cancer patients, particularly for Gram-negative bacteremia, and its routine incorporation may enhance infection management and clinical outcomes in pediatric oncology. The gene discussed is CRP; the disease is cancer.